Disease course and disability outcomes in MOG-antibody disease in the UK
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
SAGE Publications
2017
|
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
SAGE Publications
2017
|